68Ga-DOTATATE PET/CT Uptake in Prostate with an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver

Muhammad Umer Nisar, Daniel N. Costa, Liwei Jia, Orhan K. Oz, Lorraine De Blanche

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A 69-year-old man with history of metastatic neuroendocrine tumor presented for initial staging with 68Ga-DOTATE PET/CT. 68Ga-DOTATATE PET/CT showed incidental focal increased DOTATATE uptake in the left apical prostate tissue, which was thought to be of benign etiology. Digital rectal examination later was consistent with a palpable nodule along with elevated prostate-specific antigen of 7.0 ng/mL. MRI of prostate demonstrated a 3.8-cm lesion followed by a targeted biopsy that revealed prostatic acinar adenocarcinoma. Chronic inflammatory cell infiltrates were also noted on biopsy, and this may have been the cause of increased DOTATATE uptake seen on 68Ga-DOTATATE PET/CT study.

Original languageEnglish (US)
Pages (from-to)E428-E430
JournalClinical nuclear medicine
Volume46
Issue number8
DOIs
StatePublished - 2021

Keywords

  • Ga-DOTATATE
  • double primary malignancy
  • PET/CT
  • prostatic adenocarcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of '<sup>68</sup>Ga-DOTATATE PET/CT Uptake in Prostate with an Incidental Finding of Prostatic Acinar Adenocarcinoma and Metastatic Neuroendocrine Cancer to the Liver'. Together they form a unique fingerprint.

Cite this